Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-04-10 Sale |
2025-04-10 4:02 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
7,497 | $25.9 | $194,172 | 149,220 (Direct) |
View |
2024-04-10 Sale |
2024-04-10 4:03 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
7,791 | $27.55 | $214,642 | 153,329 (Direct) |
View |
2024-01-24 Sale |
2024-01-24 4:22 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
10,722 | $21.64 | $232,024 | 129,253 (Direct) |
View |
2024-01-09 Sale |
2024-01-09 4:26 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
8,391 | $22.99 | $192,909 | 116,075 (Direct) |
View |
2023-06-30 Sale |
2023-06-30 4:07 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
10,718 | $28.36 | $303,962 | 130,866 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-08 Exercise |
2025-04-10 4:02 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
15,933 | $0 | 149,220 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 4:29 pm |
N/A 2035-03-10 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FOUSE JACQUALYN A Director |
2,473 | $0 | 2,473 (Direct) |
View |
2024-06-20 Option Award |
2024-06-24 4:10 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
13,894 | $0 | 13,894 (Direct) |
View |
2024-06-13 Exercise |
2024-06-17 5:31 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
3,388 | $0 | 140,784 (Direct) |
View |
2024-06-12 Option Award |
2024-06-14 12:16 pm |
N/A 2034-06-11 |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
15,347 | $0 | 29,325 (Direct) |
View |
2024-04-08 Exercise |
2024-04-10 4:03 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
15,934 | $0 | 153,329 (Direct) |
View |
2024-01-20 Exercise |
2024-01-24 4:22 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
23,900 | $0 | 129,253 (Direct) |
View |
2024-01-05 Exercise |
2024-01-09 4:26 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
17,500 | $0 | 116,075 (Direct) |
View |
2023-06-28 Exercise |
2023-06-30 4:07 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
23,900 | $0 | 130,866 (Direct) |
View |
2023-06-14 Option Award |
2023-06-16 4:00 pm |
N/A 2033-06-13 |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
13,799 | $0 | 25,272 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 4:29 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
22,346 | $0 | 22,346 (Direct) |
View |
2023-04-12 Tax Withholding |
2023-04-12 4:17 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
4,731 | $21.35 | 125,651 (Direct) |
View |
2023-04-08 Exercise |
2023-04-12 4:17 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
15,933 | $0 | 125,651 (Direct) |
View |
2023-02-16 Tax Withholding |
2023-02-16 4:03 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
3,648 | $28.91 | 82,582 (Direct) |
View |
2023-02-14 Exercise |
2023-02-16 4:03 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Director |
11,333 | $0 | 82,582 (Direct) |
View |
2022-12-30 Option Award |
2023-01-04 4:02 pm |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
252 | $80.32 | 11,473 (Direct) |
View |
2022-09-30 Option Award |
2022-10-04 4:01 pm |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
291 | $66.64 | 11,221 (Direct) |
View |
2022-06-30 Option Award |
2022-07-01 4:01 pm |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
275 | $75.97 | 10,930 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:01 pm |
N/A 2032-06-14 |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
11,268 | $0 | 19,779 (Direct) |
View |
2022-04-08 Option Award |
2022-04-12 4:01 pm |
N/A 2032-04-08 |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer |
217,800 | $0 | 217,800 (Direct) |
View |
2022-03-31 Option Award |
2022-04-04 4:00 pm |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
280 | $79.42 | 8,511 (Direct) |
View |
2022-02-22 Tax Withholding |
2022-02-23 4:10 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer |
3,674 | $29.08 | 87,277 (Direct) |
View |
2022-02-18 Exercise |
2022-02-23 4:10 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer |
12,379 | $0 | 87,277 (Direct) |
View |
2022-02-14 Exercise |
2022-02-16 5:01 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer |
11,334 | $0 | 77,525 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-16 5:01 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer |
3,505 | $30.5 | 77,525 (Direct) |
View |
2021-12-31 Option Award |
2022-01-04 4:16 pm |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
289 | $73.4 | 8,231 (Direct) |
View |
2021-09-30 Option Award |
2021-10-04 4:32 pm |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
271 | $68.78 | 7,942 (Direct) |
View |
2021-06-30 Option Award |
2021-07-02 07:19 am |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
238 | $84.13 | 7,671 (Direct) |
View |
2021-05-26 Option Award |
2021-05-28 07:10 am |
N/A 2031-05-25 |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
9,933 | $0 | 15,443 (Direct) |
View |
2021-03-31 Option Award |
2021-04-01 5:53 pm |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
251 | $81.27 | 5,510 (Direct) |
View |
2021-02-14 Tax Withholding |
2021-02-17 4:13 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer |
3,398 | $0 | 81,030 (Direct) |
View |
2021-02-14 Exercise |
2021-02-17 4:13 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer |
11,333 | $0 | 81,030 (Direct) |
View |
2021-02-10 Option Award |
2021-02-12 4:24 pm |
N/A 2031-02-10 |
AGIOS PHARMACEUTICALS INC. | AGIO | FOUSE JACQUALYN A Chief Executive Officer |
163,000 | $0 | 163,000 (Direct) |
View |
2020-12-31 Option Award |
2021-01-05 4:51 pm |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
237 | $86.98 | 5,259 (Direct) |
View |
2020-09-30 Option Award |
2020-10-01 4:48 pm |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
219 | $89.74 | 5,022 (Direct) |
View |
2020-06-30 Option Award |
2020-07-01 6:02 pm |
N/A N/A |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
202 | $103.97 | 4,803 (Direct) |
View |
2020-05-26 Option Award |
2020-05-28 4:18 pm |
N/A 2030-05-25 |
INCYTE CORP | INCY | FOUSE JACQUALYN A Director |
11,796 | $0 | 15,115 (Direct) |
View |